Great news and good luck to Ms. Beatriz Miranda starting in her new role today as the United Nations Special Rapporteur on the Elimination of Discrimination against Persons Affected by #Leprosy

NLR India invited me to their Delhi office on 10/10/23 to discuss the PEP++ study, scientific papers on LPEP and target States of their various interventional projects. I had a very happy & enjoyable time seeing their festive decoration of the office in the traditional way.

Very interesting #blog about the terms #leprosy and Hansen’s #disease. Learn about what it means and where the words orginate from. Enjoy reading! nlrinternational.org/blogs/leprosy-…

The 3rd of December is observed as International Day of Persons with Disabilities, and this year's theme is “United in action to rescue and achieve the SDGs for, with and by persons with disabilities”. Let’s stand together to promote their rights, well-being, and empower them.

#Blog on the 150th anniversary about the #discovery by Gerhard Armauer Hansen of the bacteria that causes #leprosy. That a microorganism caused a chronic disease was a #breakthrough in #medical #history and the starting point of modern leprosy #science. nlrinternational.org/blogs/blog-150…

The film Shuddhi creates a narrative that delves into the lives of those affected by leprosy, showcasing their humanity, resilience, and struggle for dignity, NLR hopes this film will contribute significantly to raising awareness about leprosy and, in turn, inspire positive

"It is not by muscle, speed, or physical dexterity that great things are achieved, but by reflection, force of character, and judgment." - Marcus Tullius Cicero Let's reflect with 8 highlights of 2023. We believe it shows our character to continue until No Leprosy Remains.

The Leprosy Mission Bangladesh PEP++ team sharing IEC materials in Nilphamari and Rangpur districts. The materials were developed in collaboration with persons affected by leprosy following a perception study looking at what the community believes about leprosy #research

Health worker Alima (23) implements preventive treatment for leprosy in Nampula, Mozambique. She believes the project brings positive change to identify new cases, monitor index patients and stop transmission. “Through prevention we can eliminate this disease.” #WorldLeprosyDay

Today the NL parliament will debate budget cuts. The Dutch Global Health Alliance strongly advises maintaining funds for #developmentcooperation & #globalhealth for 3️⃣ reasons. Read our full statement bit.ly/4be809s

What causes leprosy and is it contagious? Plus symptoms and how it’s treated sc.mp/2nq9t?utm_sour… via @scmpnews

What does an armadillo have to do with leprosy you may wonder? Find out in this informative blog! nlrinternational.org/blogs/blog-arm… #blog #disease #leprosy

Duane Hinders, Programme Manager PEP++ Trial - explains why enhanced post-exposure prophylaxis is needed. The PEP++ trial is taking place in 4 countries that contribute over 70% of new leprosy cases. The trial is a collaboration between NLR | until No Leprosy Remains and The Leprosy Mission International

This is a reminder for you to nominate someone for this special award! #WelleslleyBaileyAwards

I attended the 18th National Task Force (NTF) Meeting of PEP++  Study virtually at New Delhi. 3 doses of combination drugs (Rifampicin+Clarithromycin) as Post Exposure Prophylaxis needs to be proved more effective than SDR. However,the final result of the study will confirm it.

"For it is in giving that we receive." - Francis of Assisi #donate

History of Leprosy in Sri Lanka: Saga of three millennia - island.lk/history-of-lep…

🩺 Tomorrow the NL parliament will debate the Global Health Strategy. The Dutch Global Health Alliance shares key asks to strengthen the implementation of the strategy. 🔗 Read more in our position article: bit.ly/3VIvn5y

Linda Hummel, Director of LRI and NLR, is opening the LRI Spring Meeting 2024 in Eindhoven. She is welcoming all participating researchers, funders and the World Health Organization (WHO), discussing important studies and innovations in leprosy over the next 3 days.